1
|
Vater C, Bräuer C, Grom S, Fecht T, Ahlfeld T, von Witzleben M, Placht AM, Schütz K, Schehl JM, Wolfram T, Reinauer F, Scharffenberg M, Wittenstein J, Hoess A, Heinemann S, Gelinsky M, Lauer G, Lode A. Poly(dl-lactide) Polymer Blended with Mineral Phases for Extrusion 3D Printing-Studies on Degradation and Biocompatibility. Polymers (Basel) 2024; 16:1254. [PMID: 38732723 PMCID: PMC11085512 DOI: 10.3390/polym16091254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2024] [Revised: 04/22/2024] [Accepted: 04/26/2024] [Indexed: 05/13/2024] Open
Abstract
A promising therapeutic option for the treatment of critical-size mandibular defects is the implantation of biodegradable, porous structures that are produced patient-specifically by using additive manufacturing techniques. In this work, degradable poly(DL-lactide) polymer (PDLLA) was blended with different mineral phases with the aim of buffering its acidic degradation products, which can cause inflammation and stimulate bone regeneration. Microparticles of CaCO3, SrCO3, tricalcium phosphates (α-TCP, β-TCP), or strontium-modified hydroxyapatite (SrHAp) were mixed with the polymer powder following processing the blends into scaffolds with the Arburg Plastic Freeforming 3D-printing method. An in vitro degradation study over 24 weeks revealed a buffer effect for all mineral phases, with the buffering capacity of CaCO3 and SrCO3 being the highest. Analysis of conductivity, swelling, microstructure, viscosity, and glass transition temperature evidenced that the mineral phases influence the degradation behavior of the scaffolds. Cytocompatibility of all polymer blends was proven in cell experiments with SaOS-2 cells. Patient-specific implants consisting of PDLLA + CaCO3, which were tested in a pilot in vivo study in a segmental mandibular defect in minipigs, exhibited strong swelling. Based on these results, an in vitro swelling prediction model was developed that simulates the conditions of anisotropic swelling after implantation.
Collapse
Affiliation(s)
- Corina Vater
- Centre for Translational Bone, Joint, and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine at Technische Universität Dresden, 01307 Dresden, Germany; (T.A.); (M.v.W.); (A.-M.P.); (K.S.); (M.G.)
| | - Christian Bräuer
- Department of Oral and Maxillofacial Surgery, University Hospital Carl Gustav Carus at Technische Universität Dresden, 01307 Dresden, Germany; (C.B.); (G.L.)
| | - Stefanie Grom
- KLS Martin SE & Co. KG, 78570 Mühlheim, Germany; (S.G.); (T.F.); (J.M.S.); (T.W.); (F.R.)
| | - Tatjana Fecht
- KLS Martin SE & Co. KG, 78570 Mühlheim, Germany; (S.G.); (T.F.); (J.M.S.); (T.W.); (F.R.)
| | - Tilman Ahlfeld
- Centre for Translational Bone, Joint, and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine at Technische Universität Dresden, 01307 Dresden, Germany; (T.A.); (M.v.W.); (A.-M.P.); (K.S.); (M.G.)
| | - Max von Witzleben
- Centre for Translational Bone, Joint, and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine at Technische Universität Dresden, 01307 Dresden, Germany; (T.A.); (M.v.W.); (A.-M.P.); (K.S.); (M.G.)
| | - Anna-Maria Placht
- Centre for Translational Bone, Joint, and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine at Technische Universität Dresden, 01307 Dresden, Germany; (T.A.); (M.v.W.); (A.-M.P.); (K.S.); (M.G.)
| | - Kathleen Schütz
- Centre for Translational Bone, Joint, and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine at Technische Universität Dresden, 01307 Dresden, Germany; (T.A.); (M.v.W.); (A.-M.P.); (K.S.); (M.G.)
| | - Jan Marc Schehl
- KLS Martin SE & Co. KG, 78570 Mühlheim, Germany; (S.G.); (T.F.); (J.M.S.); (T.W.); (F.R.)
| | - Tobias Wolfram
- KLS Martin SE & Co. KG, 78570 Mühlheim, Germany; (S.G.); (T.F.); (J.M.S.); (T.W.); (F.R.)
| | - Frank Reinauer
- KLS Martin SE & Co. KG, 78570 Mühlheim, Germany; (S.G.); (T.F.); (J.M.S.); (T.W.); (F.R.)
| | - Martin Scharffenberg
- Pulmonary Engineering Group, Department of Anesthesiology and Intensive Care Medicine, University Hospital Carl Gustav Carus at Technische Universität Dresden, 01307 Dresden, Germany; (M.S.); (J.W.)
| | - Jakob Wittenstein
- Pulmonary Engineering Group, Department of Anesthesiology and Intensive Care Medicine, University Hospital Carl Gustav Carus at Technische Universität Dresden, 01307 Dresden, Germany; (M.S.); (J.W.)
| | - Andreas Hoess
- INNOTERE GmbH, 01445 Radebeul, Germany; (A.H.); (S.H.)
| | | | - Michael Gelinsky
- Centre for Translational Bone, Joint, and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine at Technische Universität Dresden, 01307 Dresden, Germany; (T.A.); (M.v.W.); (A.-M.P.); (K.S.); (M.G.)
| | - Günter Lauer
- Department of Oral and Maxillofacial Surgery, University Hospital Carl Gustav Carus at Technische Universität Dresden, 01307 Dresden, Germany; (C.B.); (G.L.)
| | - Anja Lode
- Centre for Translational Bone, Joint, and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine at Technische Universität Dresden, 01307 Dresden, Germany; (T.A.); (M.v.W.); (A.-M.P.); (K.S.); (M.G.)
| |
Collapse
|
2
|
Maintz M, Tourbier C, de Wild M, Cattin PC, Beyer M, Seiler D, Honigmann P, Sharma N, Thieringer FM. Patient-specific implants made of 3D printed bioresorbable polymers at the point-of-care: material, technology, and scope of surgical application. 3D Print Med 2024; 10:13. [PMID: 38639834 PMCID: PMC11031859 DOI: 10.1186/s41205-024-00207-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2024] [Accepted: 03/04/2024] [Indexed: 04/20/2024] Open
Abstract
BACKGROUND Bioresorbable patient-specific additive-manufactured bone grafts, meshes, and plates are emerging as a promising alternative that can overcome the challenges associated with conventional off-the-shelf implants. The fabrication of patient-specific implants (PSIs) directly at the point-of-care (POC), such as hospitals, clinics, and surgical centers, allows for more flexible, faster, and more efficient processes, reducing the need for outsourcing to external manufacturers. We want to emphasize the potential advantages of producing bioresorbable polymer implants for cranio-maxillofacial surgery at the POC by highlighting its surgical applications, benefits, and limitations. METHODS This study describes the workflow of designing and fabricating degradable polymeric PSIs using three-dimensional (3D) printing technology. The cortical bone was segmented from the patient's computed tomography data using Materialise Mimics software, and the PSIs were designed created using Geomagic Freeform and nTopology software. The implants were finally printed via Arburg Plastic Freeforming (APF) of medical-grade poly (L-lactide-co-D, L-lactide) with 30% β-tricalcium phosphate and evaluated for fit. RESULTS 3D printed implants using APF technology showed surfaces with highly uniform and well-connected droplets with minimal gap formation between the printed paths. For the plates and meshes, a wall thickness down to 0.8 mm could be achieved. In this study, we successfully printed plates for osteosynthesis, implants for orbital floor fractures, meshes for alveolar bone regeneration, and bone scaffolds with interconnected channels. CONCLUSIONS This study shows the feasibility of using 3D printing to create degradable polymeric PSIs seamlessly integrated into virtual surgical planning workflows. Implementing POC 3D printing of biodegradable PSI can potentially improve therapeutic outcomes, but regulatory compliance must be addressed.
Collapse
Affiliation(s)
- Michaela Maintz
- Oral and Cranio-Maxillofacial Surgery, University Hospital Basel, Spitalstrasse 21, Basel, Switzerland
- Department of Biomedical Engineering, Medical Additive Manufacturing Research Group (Swiss MAM), University of Basel, Hegenheimermattweg 167C, Allschwil, Switzerland
- Institute for Medical Engineering and Medical Informatics IM², University of Applied Sciences and Arts Northwestern Switzerland FHNW, Hofackerstrasse 30, Muttenz, Switzerland
| | - Céline Tourbier
- Oral and Cranio-Maxillofacial Surgery, University Hospital Basel, Spitalstrasse 21, Basel, Switzerland.
- Department of Biomedical Engineering, Medical Additive Manufacturing Research Group (Swiss MAM), University of Basel, Hegenheimermattweg 167C, Allschwil, Switzerland.
| | - Michael de Wild
- Institute for Medical Engineering and Medical Informatics IM², University of Applied Sciences and Arts Northwestern Switzerland FHNW, Hofackerstrasse 30, Muttenz, Switzerland
| | - Philippe C Cattin
- Department of Biomedical Engineering, Center of Medical Image Analysis and Navigation (CIAN), University of Basel, Hegenheimermattweg 167C, Allschwil, Basel, Switzerland
| | - Michel Beyer
- Oral and Cranio-Maxillofacial Surgery, University Hospital Basel, Spitalstrasse 21, Basel, Switzerland
- Department of Biomedical Engineering, Medical Additive Manufacturing Research Group (Swiss MAM), University of Basel, Hegenheimermattweg 167C, Allschwil, Switzerland
| | - Daniel Seiler
- Institute for Medical Engineering and Medical Informatics IM², University of Applied Sciences and Arts Northwestern Switzerland FHNW, Hofackerstrasse 30, Muttenz, Switzerland
| | - Philipp Honigmann
- Department of Biomedical Engineering, Medical Additive Manufacturing Research Group (Swiss MAM), University of Basel, Hegenheimermattweg 167C, Allschwil, Switzerland
- Department of Orthopaedic Surgery and Traumatology, Hand- and peripheral Nerve Surgery, Kantonsspital Baselland, Bruderholz| Liestal| Laufen, Switzerland
- Biomedical Engineering and Physics, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands
| | - Neha Sharma
- Oral and Cranio-Maxillofacial Surgery, University Hospital Basel, Spitalstrasse 21, Basel, Switzerland
- Department of Biomedical Engineering, Medical Additive Manufacturing Research Group (Swiss MAM), University of Basel, Hegenheimermattweg 167C, Allschwil, Switzerland
| | - Florian M Thieringer
- Oral and Cranio-Maxillofacial Surgery, University Hospital Basel, Spitalstrasse 21, Basel, Switzerland
- Department of Biomedical Engineering, Medical Additive Manufacturing Research Group (Swiss MAM), University of Basel, Hegenheimermattweg 167C, Allschwil, Switzerland
| |
Collapse
|
3
|
Stafin K, Śliwa P, Piątkowski M. Towards Polycaprolactone-Based Scaffolds for Alveolar Bone Tissue Engineering: A Biomimetic Approach in a 3D Printing Technique. Int J Mol Sci 2023; 24:16180. [PMID: 38003368 PMCID: PMC10671727 DOI: 10.3390/ijms242216180] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2023] [Revised: 11/05/2023] [Accepted: 11/07/2023] [Indexed: 11/26/2023] Open
Abstract
The alveolar bone is a unique type of bone, and the goal of bone tissue engineering (BTE) is to develop methods to facilitate its regeneration. Currently, an emerging trend involves the fabrication of polycaprolactone (PCL)-based scaffolds using a three-dimensional (3D) printing technique to enhance an osteoconductive architecture. These scaffolds are further modified with hydroxyapatite (HA), type I collagen (CGI), or chitosan (CS) to impart high osteoinductive potential. In conjunction with cell therapy, these scaffolds may serve as an appealing alternative to bone autografts. This review discusses research gaps in the designing of 3D-printed PCL-based scaffolds from a biomimetic perspective. The article begins with a systematic analysis of biological mineralisation (biomineralisation) and ossification to optimise the scaffold's structural, mechanical, degradation, and surface properties. This scaffold-designing strategy lays the groundwork for developing a research pathway that spans fundamental principles such as molecular dynamics (MD) simulations and fabrication techniques. Ultimately, this paves the way for systematic in vitro and in vivo studies, leading to potential clinical applications.
Collapse
Affiliation(s)
- Krzysztof Stafin
- Department of Organic Chemistry and Technology, Faculty of Chemical Engineering and Technology, Cracow University of Technology, ul. Warszawska 24, PL 31-155 Kraków, Poland; (K.S.); (P.Ś.)
- Department of Biotechnology and Physical Chemistry, Faculty of Chemical Engineering and Technology, Cracow University of Technology, ul. Warszawska 24, PL 31-155 Kraków, Poland
| | - Paweł Śliwa
- Department of Organic Chemistry and Technology, Faculty of Chemical Engineering and Technology, Cracow University of Technology, ul. Warszawska 24, PL 31-155 Kraków, Poland; (K.S.); (P.Ś.)
| | - Marek Piątkowski
- Department of Biotechnology and Physical Chemistry, Faculty of Chemical Engineering and Technology, Cracow University of Technology, ul. Warszawska 24, PL 31-155 Kraków, Poland
| |
Collapse
|
4
|
Alonso-Fernández I, Haugen HJ, López-Peña M, González-Cantalapiedra A, Muñoz F. Use of 3D-printed polylactic acid/bioceramic composite scaffolds for bone tissue engineering in preclinical in vivo studies: A systematic review. Acta Biomater 2023; 168:1-21. [PMID: 37454707 DOI: 10.1016/j.actbio.2023.07.013] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2023] [Revised: 07/11/2023] [Accepted: 07/12/2023] [Indexed: 07/18/2023]
Abstract
3D-printed composite scaffolds have emerged as an alternative to deal with existing limitations when facing bone reconstruction. The aim of the study was to systematically review the feasibility of using PLA/bioceramic composite scaffolds manufactured by 3D-printing technologies as bone grafting materials in preclinical in vivo studies. Electronic databases were searched using specific search terms, and thirteen manuscripts were selected after screening. The synthesis of the scaffolds was carried out using mainly extrusion-based techniques. Likewise, hydroxyapatite was the most used bioceramic for synthesizing composites with a PLA matrix. Among the selected studies, seven were conducted in rats and six in rabbits, but the high variability that exists regarding the experimental process made it difficult to compare them. Regarding the results, PLA/Bioceramic composite scaffolds have shown to be biocompatible and mechanically resistant. Preclinical studies elucidated the ability of the scaffolds to be used as bone grafts, allowing bone growing without adverse reactions. In conclusion, PLA/Bioceramics scaffolds have been demonstrated to be a promising alternative for treating bone defects. Nevertheless, more care should be taken when designing and performing in vivo trials, since the lack of standardization of the processes, which prevents the comparison of the results and reduces the quality of the information. STATEMENT OF SIGNIFICANCE: 3D-printed polylactic acid/bioceramic composite scaffolds have emerged as an alternative to deal with existing limitations when facing bone reconstruction. Since preclinical in vivo studies with animal models represent a mandatory step for clinical translation, the present manuscript analyzed and discussed not only those aspects related to the selection of the bioceramic material, the synthesis of the implants and their characterization. But provides a new approach to understand how the design and perform of clinical trials, as well as the selection of the analysis methods, may affect the obtained results, by covering authors' knowledgebase from veterinary medicine to biomaterial science. Thus, this study aims to systematically review the feasibility of using polylactic acid/bioceramic scaffolds as grafting materials in preclinical trials.
Collapse
Affiliation(s)
- Iván Alonso-Fernández
- Anatomy, Animal Production and Veterinary Clinical Sciences Department, Veterinary Faculty, Universidade de Santiago de Compostela, Campus Universitario s/n, 27002 Lugo, Spain.
| | - Håvard Jostein Haugen
- Department of Biomaterials, Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo, Oslo, Norway
| | - Mónica López-Peña
- Anatomy, Animal Production and Veterinary Clinical Sciences Department, Veterinary Faculty, Universidade de Santiago de Compostela, Campus Universitario s/n, 27002 Lugo, Spain
| | - Antonio González-Cantalapiedra
- Anatomy, Animal Production and Veterinary Clinical Sciences Department, Veterinary Faculty, Universidade de Santiago de Compostela, Campus Universitario s/n, 27002 Lugo, Spain
| | - Fernando Muñoz
- Anatomy, Animal Production and Veterinary Clinical Sciences Department, Veterinary Faculty, Universidade de Santiago de Compostela, Campus Universitario s/n, 27002 Lugo, Spain
| |
Collapse
|
5
|
Ahlfeld T, Lode A, Placht AM, Fecht T, Wolfram T, Grom S, Hoess A, Vater C, Bräuer C, Heinemann S, Lauer G, Reinauer F, Gelinsky M. A comparative analysis of 3D printed scaffolds consisting of poly(lactic- co-glycolic) acid and different bioactive mineral fillers: aspects of degradation and cytocompatibility. Biomater Sci 2023; 11:5590-5604. [PMID: 37403758 DOI: 10.1039/d2bm02071h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/06/2023]
Abstract
Their excellent mechanical properties, degradability and suitability for processing by 3D printing technologies make the thermoplastic polylactic acid and its derivatives favourable candidates for biomaterial-based bone regeneration therapies. In this study, we investigated whether bioactive mineral fillers, which are known to promote bone healing based on their dissolution products, can be integrated into a poly(L-lactic-co-glycolic) acid (PLLA-PGA) matrix and how key characteristics of degradation and cytocompatibility are influenced. The polymer powder was mixed with particles of CaCO3, SrCO3, strontium-modified hydroxyapatite (SrHAp) or tricalcium phosphates (α-TCP, β-TCP) in a mass ratio of 90 : 10; the resulting composite materials have been successfully processed into scaffolds by the additive manufacturing method Arburg Plastic Freeforming (APF). Degradation of the composite scaffolds was investigated in terms of dimensional change, bioactivity, ion (calcium, phosphate, strontium) release/uptake and pH development during long-term (70 days) incubation. The mineral fillers influenced the degradation behavior of the scaffolds to varying degrees, with the calcium phosphate phases showing a clear buffer effect and an acceptable dimensional increase. The amount of 10 wt% SrCO3 or SrHAp particles did not appear to be appropriate to release a sufficient amount of strontium ions to exert a biological effect in vitro. Cell culture experiments with the human osteosarcoma cell line SAOS-2 and human dental pulp stem cells (hDPSC) indicated the high cytocompatibility of the composites: For all material groups cell spreading and complete colonization of the scaffolds over the culture period of 14 days as well as an increase of the specific alkaline phosphatase activity, typical for osteogenic differentiation, were observed.
Collapse
Affiliation(s)
- Tilman Ahlfeld
- Centre for Translational Bone, Joint and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
| | - Anja Lode
- Centre for Translational Bone, Joint and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
| | - Anna-Maria Placht
- Centre for Translational Bone, Joint and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
| | - Tatjana Fecht
- Karl Leibinger Medizintechnik GmbH & Co. KG (KLS Martin Group), Germany
| | - Tobias Wolfram
- Karl Leibinger Medizintechnik GmbH & Co. KG (KLS Martin Group), Germany
| | - Stefanie Grom
- Karl Leibinger Medizintechnik GmbH & Co. KG (KLS Martin Group), Germany
| | | | - Corina Vater
- Centre for Translational Bone, Joint and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
| | - Christian Bräuer
- Department of Oral and Maxillofacial Surgery, University Hospital Carl Gustav Carus and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
| | | | - Günter Lauer
- Department of Oral and Maxillofacial Surgery, University Hospital Carl Gustav Carus and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
| | - Frank Reinauer
- Karl Leibinger Medizintechnik GmbH & Co. KG (KLS Martin Group), Germany
| | - Michael Gelinsky
- Centre for Translational Bone, Joint and Soft Tissue Research, University Hospital Carl Gustav Carus and Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
| |
Collapse
|
6
|
Gao N, Fu Y, Gong H, Liu H, Li W. Hyaluronic acid and cholecalciferol conjugate based nanomicelles: Synthesis, characterization, and cytotoxicity against MCF-7 breast cancer cells. Carbohydr Res 2022; 522:108706. [DOI: 10.1016/j.carres.2022.108706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2022] [Revised: 10/11/2022] [Accepted: 10/11/2022] [Indexed: 11/16/2022]
|
7
|
Thurzo A, Gálfiová P, Nováková ZV, Polák Š, Varga I, Strunga M, Urban R, Surovková J, Leško Ľ, Hajdúchová Z, Feranc J, Janek M, Danišovič Ľ. Fabrication and In Vitro Characterization of Novel Hydroxyapatite Scaffolds 3D Printed Using Polyvinyl Alcohol as a Thermoplastic Binder. Int J Mol Sci 2022; 23:ijms232314870. [PMID: 36499194 PMCID: PMC9736063 DOI: 10.3390/ijms232314870] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2022] [Revised: 11/23/2022] [Accepted: 11/24/2022] [Indexed: 11/29/2022] Open
Abstract
This paper presents a proof-of-concept study on the biocolonization of 3D-printed hydroxyapatite scaffolds with mesenchymal stem cells (MSCs). Three-dimensional (3D) printed biomimetic bone structure made of calcium deficient hydroxyapatite (CDHA) intended as a future bone graft was made from newly developed composite material for FDM printing. The biopolymer polyvinyl alcohol serves in this material as a thermoplastic binder for 3D molding of the printed object with a passive function and is completely removed during sintering. The study presents the material, the process of fused deposition modeling (FDM) of CDHA scaffolds, and its post-processing at three temperatures (1200, 1300, and 1400 °C), as well it evaluates the cytotoxicity and biocompatibility of scaffolds with MTT and LDH release assays after 14 days. The study also includes a morphological evaluation of cellular colonization with scanning electron microscopy (SEM) in two different filament orientations (rectilinear and gyroid). The results of the MTT assay showed that the tested material was not toxic, and cells were preserved in both orientations, with most cells present on the material fired at 1300 °C. Results of the LDH release assay showed a slight increase in LDH leakage from all samples. Visual evaluation of SEM confirmed the ideal post-processing temperature of the 3D-printed FDM framework for samples fired at 1300 °C and 1400 °C, with a porosity of 0.3 mm between filaments. In conclusion, the presented fabrication and colonization of CDHA scaffolds have great potential to be used in the tissue engineering of bones.
Collapse
Affiliation(s)
- Andrej Thurzo
- Department of Orthodontics, Regenerative and Aesthetic Dentistry, Faculty of Medicine, Comenius University, 81250 Bratislava, Slovakia
- Correspondence: (A.T.); (Ľ.D.)
| | - Paulína Gálfiová
- Institute of Histology and Embryology, Faculty of Medicine, Comenius University, 81104 Bratislava, Slovakia
| | - Zuzana Varchulová Nováková
- Institute of Medical Biology, Genetics and Clinical Genetic, Faculty of Medicine, Comenius University, 81108 Bratislava, Slovakia
- National Institute of Rheumatic Diseases, 92112 Piešťany, Slovakia
| | - Štefan Polák
- Institute of Histology and Embryology, Faculty of Medicine, Comenius University, 81104 Bratislava, Slovakia
| | - Ivan Varga
- Institute of Histology and Embryology, Faculty of Medicine, Comenius University, 81104 Bratislava, Slovakia
| | - Martin Strunga
- Department of Orthodontics, Regenerative and Aesthetic Dentistry, Faculty of Medicine, Comenius University, 81250 Bratislava, Slovakia
| | - Renáta Urban
- Department of Orthodontics, Regenerative and Aesthetic Dentistry, Faculty of Medicine, Comenius University, 81250 Bratislava, Slovakia
| | - Jana Surovková
- Department of Orthodontics, Regenerative and Aesthetic Dentistry, Faculty of Medicine, Comenius University, 81250 Bratislava, Slovakia
| | - Ľuboš Leško
- Institute of Medical Biology, Genetics and Clinical Genetic, Faculty of Medicine, Comenius University, 81108 Bratislava, Slovakia
| | - Zora Hajdúchová
- Department of Inorganic Materials, Faculty of Chemical and Food Technology, Slovak University of Technology, 81237 Bratislava, Slovakia
| | - Jozef Feranc
- Department of Plastics, Rubber and Fibres, Faculty of Chemical and Food Technology, Slovak University of Technology, 81237 Bratislava, Slovakia
| | - Marian Janek
- Department of Inorganic Materials, Faculty of Chemical and Food Technology, Slovak University of Technology, 81237 Bratislava, Slovakia
- Department of Physical and Theoretical Chemistry, Faculty of Natural Sciences, Comenius University, 84215 Bratislava, Slovakia
| | - Ľuboš Danišovič
- Institute of Medical Biology, Genetics and Clinical Genetic, Faculty of Medicine, Comenius University, 81108 Bratislava, Slovakia
- National Institute of Rheumatic Diseases, 92112 Piešťany, Slovakia
- Correspondence: (A.T.); (Ľ.D.)
| |
Collapse
|